Zenysis Technologies Has Closed A $13.3Million Series B round Led By The Steele Foundation for Hope

Venture capital investor; Peter Thiel and Silicon Valley venture capital firm; 500 Startups also participated in the round.

Zenysis’ data integration and advanced analytics platform enable decision-makers to mine vast stores of siloed information for insights they can use to improve public health and respond to humanitarian emergencies. 

Governments in nine low- and middle-income countries across three continents use Zenysis’ software to fight infectious disease outbreaks, increase childhood vaccination rates and deliver a wide range of health programs in a data-driven way.

We are excited about our partnership with the Steele Foundation for Hope, which shares our values and has backed our mission with conviction,” said Jonathan Stambolis, co-founder and CEO, Zenysis Technologies. “This investment will allow us to triple our global footprint over the next two years and invest in the innovations and partnerships that will improve public health outcomes around the world, especially in low- and middle-income countries,” he added.

Founded in late 2021, SFFH aims to be a lead investor in startups that employ innovative technologies to improve the lives of people in places overlooked by conventional venture capital. At the request of SFFH, the terms of Zenysis’ financing did not include a board seat.

The foundation set an impressive pace with its first investment by completing the financing within 21 days of signing its term sheet with Zenysis Technologies.

We structure our program-related investments to provide capital quickly, without unnecessary interference or onerous reporting requirements,” said Joe Exner, Chief Executive Officer, Steele Foundation for Hope. 

Exit mobile version